Bergisch-Gladbach, Germany

Olaf Queckenberg



Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Olaf Queckenberg: A Trailblazer in Pharmaceutical Chemistry

Introduction

Olaf Queckenberg, a prominent inventor based in Bergisch-Gladbach, Germany, has made significant contributions to the field of pharmaceutical chemistry. His work focuses on novel compounds that have the potential to enhance disease management. With one patent to his name, Queckenberg exemplifies the spirit of innovation that drives scientific progress.

Latest Patents

Queckenberg's notable patent is a co-crystal compound of rivaroxaban and malonic acid. This inventive compound is associated with the medicinal properties of rivaroxaban, a key agent in the treatment and management of various diseases. The patent outlines the processes for the preparation of this compound and its applicability in the creation of medicaments designed to control ailments, showcasing the intersection of chemistry and healthcare.

Career Highlights

Olaf Queckenberg is affiliated with Bayer Intellectual Property GmbH, where he has cultivated an environment rich in research and development. His role at this esteemed company not only underscores his expertise in developing innovative solutions but also highlights the collaborative nature of his work in the pharmaceutical industry.

Collaborations

Throughout his career, Queckenberg has collaborated with accomplished colleagues such as Alfons Grunenberg and Karsten Fähnrich. These partnerships foster a creative and productive atmosphere that enhances the development of new ideas and compounds essential for pharmaceutical advancements.

Conclusion

Olaf Queckenberg stands as a testament to the vital role of inventors in shaping the future of healthcare through innovation. His contributions, particularly the co-crystal compound of rivaroxaban and malonic acid, exemplify the kind of groundbreaking work that can emerge from collaboration and a deep understanding of chemical processes. As the pharmaceutical landscape continues to evolve, inventors like Queckenberg will remain at the forefront, pushing the boundaries of what is possible in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…